Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00033254 · ClinicalTrials.gov registry record · Phase 3
Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
A Phase 3 study of Tumors Metastatic to Brain, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 3
- Development phase
- 332
- Enrollment target
- 1
- Study location
NCT00033254 is a Phase 3 study of Tumors Metastatic to Brain that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 332 participants, above the 32-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (938% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00033254, a Phase 3 study of Tumors Metastatic to Brain, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 332 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized phase III trial to compare the effectiveness of radiation therapy with or without thalidomide in treating patients who have brain metastases. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as thalidomide may stop the growth of brain metastases by stopping blood flow to the tumor. It is not yet known whether radiation therapy is more effective with or without thalidomide in treating brain metastases.
Conditions Studied
Interventions
- PROCEDURE quality-of-life assessment
- RADIATION radiation therapy
- DRUG thalidomide
Study Locations (1)
Pennsylvania
- Radiation Therapy Oncology Group - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2002-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00033254
The ClinicalTrials.gov registry entry for NCT00033254 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 32-participant average among 4 other Tumors Metastatic to Brain trials with a reported enrollment target (938% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tumors Metastatic to Brain appearing as the primary indexed condition, and to 3 interventions - of which quality-of-life assessment is the first listed.
NCT00033254 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00033254 about?
NCT00033254 is a clinical study titled "Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases". Randomized phase III trial to compare the effectiveness of radiation therapy with or without thalidomide in treating patients who have brain metastases. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs such as thalidomide may stop the growth of brain metastases by stopping bloo...
What is the current status of trial NCT00033254?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 332 participants. The study started on 2002-03.
What conditions does trial NCT00033254 study?
This clinical trial studies the following conditions: Tumors Metastatic to Brain.
What interventions are being tested in trial NCT00033254?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), radiation therapy (RADIATION), thalidomide (DRUG).
Who is sponsoring clinical trial NCT00033254?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00033254 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tumors Metastatic to Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
RECRUITING · Phase 1
-
Stereotactic Radiosurgery in Treating Patients With Large Brain Metastases
ACTIVE NOT RECRUITING · Phase 1
-
Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to Melanoma
COMPLETED · Phase 2
-
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.